{"id":"https://openalex.org/W1546941007","doi":"https://doi.org/10.1111/j.1476-5381.2012.01971.x","title":"Neuroprotective and neurotrophic actions of glucagon\u2010like peptide\u20101: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders","display_name":"Neuroprotective and neurotrophic actions of glucagon\u2010like peptide\u20101: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders","alternate_titles":[],"publication_year":2012,"publication_date":"2012-04-20","ids":{"openalex":"https://openalex.org/W1546941007","doi":"https://doi.org/10.1111/j.1476-5381.2012.01971.x","mag":"1546941007","pmid":"https://pubmed.ncbi.nlm.nih.gov/22519295","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3419902"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.2012.01971.x","doi":"https://doi.org/10.1111/j.1476-5381.2012.01971.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2012.01971.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2012.01971.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1546941007"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2012.01971.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041705273","display_name":"Isidro Salcedo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Isidro Salcedo","raw_affiliation_strings":["Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031854067","display_name":"David Tweedie","orcid":"https://orcid.org/0000-0002-8446-4544","observed_orcids":["https://orcid.org/0000-0002-8446-4544"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Tweedie","raw_affiliation_strings":["Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100669061","display_name":"Yazhou Li","orcid":"https://orcid.org/0000-0002-6048-3660","observed_orcids":["https://orcid.org/0000-0002-6048-3660"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yazhou Li","raw_affiliation_strings":["Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056649584","display_name":"Nigel H. Greig","orcid":"https://orcid.org/0000-0002-3032-1468","observed_orcids":["https://orcid.org/0000-0002-3032-1468"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nigel H Greig","raw_affiliation_strings":["Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5056649584"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210136897"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.499,"has_fulltext":true,"cited_by_count":288,"citation_normalized_percentile":{"value":0.82748815,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"166","issue":"5","first_page":"1586","last_page":"1599"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.4494999945163727,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.4494999945163727,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.16750000417232513,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.16590000689029694,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":1.0},{"id":"https://openalex.org/keywords/glp-1-receptor","display_name":"GLP-1 receptor","score":0.9340000152587891},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9900000095367432},{"id":"https://openalex.org/keywords/neurotrophic-effects","display_name":"neurotrophic effects","score":0.8629999756813049},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.9120000004768372},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.5690000057220459},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9779999852180481},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9919999837875366},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":1.0},{"id":"https://openalex.org/keywords/neurogenesis","display_name":"neurogenesis","score":0.7720000147819519},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.7670000195503235},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9950000047683716},{"id":"https://openalex.org/keywords/shared-pathophysiology","display_name":"shared pathophysiology","score":0.5350000262260437},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.7450000047683716}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.8195614814758301},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.6678042411804199},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5837737321853638},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5565339922904968},{"id":"https://openalex.org/C160539049","wikidata":"https://www.wikidata.org/wiki/Q3064187","display_name":"Neurotrophic factors","level":3,"score":0.5545140504837036},{"id":"https://openalex.org/C92020748","wikidata":"https://www.wikidata.org/wiki/Q420457","display_name":"Neurotrophin","level":3,"score":0.4920503497123718},{"id":"https://openalex.org/C2984863031","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Cognitive decline","level":4,"score":0.4498721957206726},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.4459289014339447},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.43869924545288086},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.42134976387023926},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.4168151915073395},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.29806262254714966},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.29569941759109497},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28769493103027344},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23870491981506348},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.21763014793395996},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20514094829559326},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.18377333879470825},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.16238391399383545},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.14656424522399902},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002561","descriptor_name":"Cerebrovascular Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019636","descriptor_name":"Neurodegenerative Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1476-5381.2012.01971.x","doi":"https://doi.org/10.1111/j.1476-5381.2012.01971.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2012.01971.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2012.01971.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3481810","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3419902","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:22519295","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22519295","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3419902","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3419902/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.2012.01971.x","doi":"https://doi.org/10.1111/j.1476-5381.2012.01971.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2012.01971.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2012.01971.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1546941007.pdf","grobid_xml":"https://content.openalex.org/works/W1546941007.grobid-xml"},"referenced_works_count":123,"referenced_works":["https://openalex.org/W16655179","https://openalex.org/W911598418","https://openalex.org/W1270261677","https://openalex.org/W1515929023","https://openalex.org/W1525058897","https://openalex.org/W1535374793","https://openalex.org/W1535426243","https://openalex.org/W1543788907","https://openalex.org/W1658884838","https://openalex.org/W1963640549","https://openalex.org/W1965263019","https://openalex.org/W1967256054","https://openalex.org/W1969492297","https://openalex.org/W1970095022","https://openalex.org/W1971591150","https://openalex.org/W1978769917","https://openalex.org/W1979509360","https://openalex.org/W1979632477","https://openalex.org/W1979656222","https://openalex.org/W1980147075","https://openalex.org/W1981755758","https://openalex.org/W1982613439","https://openalex.org/W1982773178","https://openalex.org/W1985241513","https://openalex.org/W1985305554","https://openalex.org/W1986462996","https://openalex.org/W1989616977","https://openalex.org/W1990234745","https://openalex.org/W1990306590","https://openalex.org/W1990366009","https://openalex.org/W1990441398","https://openalex.org/W1991652381","https://openalex.org/W1992788138","https://openalex.org/W1993465897","https://openalex.org/W1995762768","https://openalex.org/W1996893328","https://openalex.org/W1997358531","https://openalex.org/W1998869094","https://openalex.org/W1999264674","https://openalex.org/W2000115601","https://openalex.org/W2002805781","https://openalex.org/W2006254635","https://openalex.org/W2006568691","https://openalex.org/W2009090653","https://openalex.org/W2009582310","https://openalex.org/W2010202880","https://openalex.org/W2015739629","https://openalex.org/W2016932677","https://openalex.org/W2021375788","https://openalex.org/W2021454079","https://openalex.org/W2023819682","https://openalex.org/W2023899218","https://openalex.org/W2024363942","https://openalex.org/W2024409703","https://openalex.org/W2028099278","https://openalex.org/W2030198351","https://openalex.org/W2030270894","https://openalex.org/W2032444015","https://openalex.org/W2033870982","https://openalex.org/W2034351576","https://openalex.org/W2035820774","https://openalex.org/W2038523007","https://openalex.org/W2039012096","https://openalex.org/W2040014587","https://openalex.org/W2043673143","https://openalex.org/W2045600065","https://openalex.org/W2045846363","https://openalex.org/W2052504477","https://openalex.org/W2054388625","https://openalex.org/W2055499860","https://openalex.org/W2056102057","https://openalex.org/W2058723245","https://openalex.org/W2061274996","https://openalex.org/W2062833196","https://openalex.org/W2065789765","https://openalex.org/W2067204442","https://openalex.org/W2069612190","https://openalex.org/W2070847811","https://openalex.org/W2071472708","https://openalex.org/W2072622635","https://openalex.org/W2077445047","https://openalex.org/W2078715993","https://openalex.org/W2080785707","https://openalex.org/W2081569845","https://openalex.org/W2084071446","https://openalex.org/W2085273105","https://openalex.org/W2086177834","https://openalex.org/W2089944792","https://openalex.org/W2090150925","https://openalex.org/W2091674068","https://openalex.org/W2092833954","https://openalex.org/W2099976535","https://openalex.org/W2100168188","https://openalex.org/W2100826172","https://openalex.org/W2101425299","https://openalex.org/W2102071852","https://openalex.org/W2102585787","https://openalex.org/W2103154453","https://openalex.org/W2106339546","https://openalex.org/W2107387649","https://openalex.org/W2109274811","https://openalex.org/W2109727228","https://openalex.org/W2110279292","https://openalex.org/W2120467396","https://openalex.org/W2121642311","https://openalex.org/W2123431154","https://openalex.org/W2124852816","https://openalex.org/W2128815118","https://openalex.org/W2129085204","https://openalex.org/W2129659524","https://openalex.org/W2136957706","https://openalex.org/W2138677261","https://openalex.org/W2152355721","https://openalex.org/W2152880048","https://openalex.org/W2152958765","https://openalex.org/W2158439853","https://openalex.org/W2159205789","https://openalex.org/W2160560427","https://openalex.org/W2163909553","https://openalex.org/W2164948885","https://openalex.org/W2182063174","https://openalex.org/W2202893527","https://openalex.org/W2400990677"],"related_works":["https://openalex.org/W3084110076","https://openalex.org/W2078613171","https://openalex.org/W2050875709","https://openalex.org/W3159277791","https://openalex.org/W4311761391","https://openalex.org/W4308952350","https://openalex.org/W4410197519","https://openalex.org/W4294162864","https://openalex.org/W2013794398"],"abstract_inverted_index":{"Like":[0],"type-2":[1],"diabetes":[2],"mellitus":[3],"(T2DM),":[4],"neurodegenerative":[5,44,71,93],"disorders":[6,72],"and":[7,15,43,75,80,90,97,107,125,138,199,213,250],"stroke":[8,108],"are":[9,58,73],"an":[10,24,86,103,150,172,208,243],"ever":[11],"increasing,":[12],"health,":[13],"social":[14],"economic":[16],"burden":[17],"for":[18,153,248],"developed":[19],"Westernized":[20],"countries.":[21],"Age":[22],"is":[23,102],"important":[25],"risk":[26],"factor":[27],"in":[28,38,141,159,193,207,220,230],"all":[29],"of":[30,70,135,189,202,211,228,239],"these;":[31],"due":[32],"to":[33,51,61,66,176,184],"the":[34,39,133,160,225,231,236],"rapidly":[35],"increasing":[36,209],"rise":[37],"elderly":[40],"population":[41],"T2DM":[42,89,106],"disorders,":[45,94],"both":[46],"represent":[47,76],"a":[48,77,197],"looming":[49],"threat":[50],"healthcare":[52],"systems.":[53],"Whereas":[54],"several":[55],"efficacious":[56],"drugs":[57,166],"currently":[59],"available":[60],"ameliorate":[62],"T2DM,":[63],"effective":[64,151,173],"treatments":[65],"counteract":[67],"pathogenic":[68],"processes":[69],"lacking":[74],"major":[78,92],"scientific":[79],"pharmaceutical":[81],"challenge.":[82],"Epidemiological":[83],"data":[84],"indicate":[85],"association":[87,104],"between":[88,105],"most":[91],"including":[95,117],"Alzheimer's":[96],"Parkinson's":[98],"diseases.":[99],"Likewise,":[100],"there":[101],"incidence.":[109],"Studies":[110],"have":[111,167],"revealed":[112],"that":[113,149],"common":[114],"pathophysiological":[115],"features,":[116],"oxidative":[118],"stress,":[119],"insulin":[120],"resistance,":[121],"abnormal":[122],"protein":[123],"processing":[124],"cognitive":[126],"decline,":[127],"occur":[128],"across":[129],"these.":[130],"Based":[131],"on":[132],"presence":[134],"shared":[136],"mechanisms":[137],"signalling":[139],"pathways":[140],"these":[142],"seemingly":[143],"distinct":[144],"diseases,":[145],"one":[146,154],"could":[147,156],"hypothesize":[148],"treatment":[152,246],"disorder":[155],"prove":[157],"beneficial":[158],"others.":[161],"Glucagon-like":[162],"peptide-1":[163],"(GLP-1)-based":[164],"anti-diabetic":[165],"drawn":[168],"particular":[169],"attention":[170],"as":[171,217,219,242],"new":[174],"strategy":[175,247],"not":[177],"only":[178],"regulate":[179],"blood":[180],"glucose":[181],"but":[182],"also":[183],"reduce":[185],"apoptotic":[186],"cell":[187],"death":[188],"pancreatic":[190],"beta":[191],"cells":[192],"T2DM.":[194],"Evidence":[195],"supports":[196],"neurotrophic":[198],"neuroprotective":[200],"role":[201,227],"GLP-1":[203,229],"receptor":[204],"(R)":[205],"stimulation":[206,241],"array":[210],"cellular":[212],"animal":[214],"neurodegeneration":[215],"models":[216],"well":[218],"neurogenesis.":[221],"Herein,":[222],"we":[223],"review":[224],"physiological":[226],"nervous":[232],"system,":[233],"focused":[234],"towards":[235],"potential":[237],"benefit":[238],"GLP-1R":[240],"immediately":[244],"translatable":[245],"acute":[249],"chronic":[251],"neurological":[252],"disorders.":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1546941007","counts_by_year":[{"year":2026,"cited_by_count":20},{"year":2025,"cited_by_count":28},{"year":2024,"cited_by_count":30},{"year":2023,"cited_by_count":22},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":21},{"year":2020,"cited_by_count":26},{"year":2019,"cited_by_count":19},{"year":2018,"cited_by_count":25},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":21},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
